Skip to content

Clinical trials

Phase 4 Schizophrenia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 4 Country / region: United States Clear all

192 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20017
20023
200318
200416
200517
200619
200712
20089
200912
20105
20115
20124
20133
20147
20154
20163
20173
20184
20196
20202
20222
20234
20244
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed149
Terminated16
Recruiting10
Unknown status9
Not yet recruiting4
Withdrawn4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital15
Eli Lilly and Company11
University of California, Los Angeles10
University of Maryland, Baltimore10
North Suffolk Mental Health Association7
Northwell Health7
University of Massachusetts, Worcester7
Nathan Kline Institute for Psychiatric Research6
National Institute of Mental Health (NIMH)6
Dartmouth-Hitchcock Medical Center5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia192
Psychotic Disorders107
Bipolar Disorder20
Alcoholism8
Diabetes Mellitus8
Insulin Resistance8
Substance-Related Disorders8
Major Depressive Disorder7
Cognitive Dysfunction6
Obesity6

Trials

Showing 1 to 25 of 192. Each trial links to its page on Pharma Observatory.

92 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.